←
Avner Schlessinger2,051 posts
Avner Schlessinger avatar

Avner Schlessinger

@SchlessingerLab

Computational biologist. Professor. Co-Director of Disease Mechanisms and Therapeutics Training Area @IcahnMountSinai. Opinions are mine. #DrugDesign #AI

◷ Joined September 2017▧ 198 Photos and videos
Avner Schlessinger avatar
Avner Schlessinger@SchlessingerLab·14 Oct 2025

Check out this excellent @cenmag piece by @AayushiPratap on how AI is transforming drug discovery. Our work at @IcahnMountSinai Mount Sinai’s AI Small Molecule Drug Discovery Center is featured. cen.acs.org/physical-chemist… #AI #DrugDiscovery #Pharma

Icahn School of Medicine at Mount Sinai avatar
⟳ Avner Schlessinger retweeted
Icahn School of Medicine at Mount Sinai@IcahnMountSinai·Jul 31

Scientists at Mount Sinai have uncovered the first high-resolution structure of NBCn2, a brain protein linked to epilepsy, autism spectrum disorder, and other neurological conditions, and developed the first compounds capable of inhibiting its activity. Published in @NatureComms, the study used cryo-electron microscopy to capture the first highly detailed structural images of NBCn2, revealing how it transports sodium and carbonate ions that help regulate cellular acidity and control brain cell activity. The researchers also found that the way NBCn2 binds these ions differs from related proteins, suggesting that even closely related transporters may operate in distinct ways. The findings could help researchers better study disorders involving excessive neuronal activity and provide a new framework for understanding how altered brain signaling contributes to disease — potentially advancing future therapeutic research. Learn more about the research: mshs.co/4pRRvYy @MSHSNeurology @SinaiBrain @SinaiGenetics @SchlessingerLab #Neuroscience #Research #BrainResearch #Epilepsy

Post attachment
J. Am. Chem. Soc. avatar
⟳ Avner Schlessinger retweeted
J. Am. Chem. Soc.@J_A_C_S·Jun 3

Allosteric Inhibition of PKMYT1 Induces a Unique, Inactive ATP Binding Site Conformation | Journal of the American Chemical Society pubs.acs.org/doi/10.1021/jac…

Avner Schlessinger avatar
Avner Schlessinger@SchlessingerLab·Jun 3

AI accurately captured a known kinase conformation, but missed the cryptic pocket observed experimentally. We also found that subtle chemical changes can shift molecules between distinct binding modes, highlighting the need to combine computation and experiments in drug discovery

Avner Schlessinger avatar
Avner Schlessinger@SchlessingerLab·Jun 3

New paper from the lab. Using AI-guided modeling and experiments, we identified a hidden allosteric pocket in the cancer kinase PKMYT1. Led by @NHerrington24 in collaboration with @LazarusLab pubs.acs.org/doi/full/10.102…

Avner Schlessinger avatar
Avner Schlessinger@SchlessingerLab·Feb 4

Great The Scientist piece: two harmful mutations can restore protein function—challenging how we view genetic risk. I share my take on the structural logic behind this and relevance to drug discovery. My perspective the-scientist.com/two-harmfu… Original study pnas.org/doi/10.1073/pnas.25…

Avner Schlessinger avatar
Avner Schlessinger@SchlessingerLab·23 Dec 2025

My interview with Technology Networks on rethinking target-based drug discovery. We discuss why target-first approaches often fail and how AI and structure-guided methods can better link targets to therapeutic impact. tinyurl.com/5evzw7h8 #DrugDiscovery #AIDrugDiscovery 🔗

Avner Schlessinger avatar
Avner Schlessinger@SchlessingerLab·16 Dec 2025

Check out our new paper introducing V2P — a method that predicts both variant pathogenicity and disease phenotype across 23 HPO categories. With @ItanLab and @david_stientist and others nature.com/articles/s41467-0… Server: v2p.ai

C&EN (Chemical & Engineering News) avatar
⟳ Avner Schlessinger retweeted
C&EN (Chemical & Engineering News)@cenmag·14 Oct 2025

Artificial intelligence and machine learning are being embedded in every aspect of the drug discovery and development process. Despite AI’s use at each step, the billion-dollar question is whether it can bring a larger number of novel drugs to market. cen.acs.org/physical-chemist…